Both in Pharmaceuticals
Akebia Therapeutics vs Whitehawk Therapeutics
Over the past year AKBA returned −66.7% and WHWK returned +45.9%; their daily moves had a correlation of 0.11.
AKBA −66.7% WHWK +45.9%Growth of $1, one year, split-adjusted
| Metric | AKBA | WHWK |
|---|---|---|
| Price | $0.7065 | $3.24 |
| Market cap | $195.8M | $184.7M |
| Today | −4.81% | −1.82% |
| 1 month | −18.9% | −13.8% |
| 6 months | −49.5% | −18.8% |
| Year to date | −56.1% | +33.9% |
| 1 year | −66.4% | +31.7% |
| Revenue growth (YoY) | −21.4% | — |
| Gross margin | 78.8% | — |
| Net margin | −18.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $106.0M | $190.0M |
| Dividend yield | — | — |
| Volatility (60d) | 73.8% | 51.9% |
| Short % of float | 8.7% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).